Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × dapagliflozin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Solid Tumors 1 Pediatric Brain Tumor 1 Lung Neoplasms 1 Inflammation 1 Heart Failure 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Adenocarcinoma of Lung 1

Interventions

Standard of Care 2 Rituximab 2 Nutrition Assessment 2 Lenalidomide 2 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 empagliflozin 1 dapagliflozin 1 acalabrutinib 1 Vincristine 1 Vascular Stiffness 1 Valsartan 1 Trastuzumab 1 Specimen Handling 1 Pulse Wave Analysis 1 Prednisolone 1 Practice Guidelines as Topic 1 Palliative Care 1 Ogivri 1 Mesenchymal Stem Cell Transplantation 1 Health Information Exchange 1 Exercise 1 Eplerenone 1 Electronic Health Records 1 Electrocardiography 1 Echocardiography 1 Doxorubicin 1 Dexrazoxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07245069 2025-11-24

Alpaca

University Medical Centre Ljubljana

Phase 2 Recruiting

Breast Neoplasms, Heart Failure, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡